Overview A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2) Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis. Phase: Phase 2 Details Lead Sponsor: Kissei Pharmaceutical Co., Ltd.